{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T13:24:20Z","timestamp":1783085060924,"version":"3.54.6"},"reference-count":50,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"unspecified","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2026,6,9]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Familial Mediterranean fever (FMF) is an autoinflammatory disease caused by mutations in the\n                      <jats:italic>MEFV<\/jats:italic>\n                      gene. Despite therapeutic advances with colchicine and interleukin-1 (IL-1) inhibitors, FMF shows marked interindividual variability, including among symptomatic heterozygotes, challenging genotype-phenotype correlations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To identify clinically meaningful subgroups of paediatric patients with FMF using a clustering approach and to characterise their clinical features and disease trajectories.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a monocentric retrospective study including 185 paediatric patients diagnosed with FMF between 2004 and 2025 according to Eurofever criteria. Patients were stratified as genetically confirmed FMF (homozygous, compound heterozygous) or symptomatic heterozygotes. Demographic, clinical, laboratory and treatment data were collected longitudinally. Clustering analysis was used to identify clinically meaningful subgroups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The median age at onset was 2.5 years and the median diagnostic delay was 24 months. Ninety-three (50%) patients were symptomatic heterozygotes. Compared with genetically confirmed FMF, heterozygotes had milder disease, lower colchicine doses and less frequent IL-1 inhibitor use. Cluster analysis identified five distinct subgroups, ranging from asymptomatic or mild heterozygotes without treatment to early-onset homozygous patients with severe disease requiring higher-dose colchicine and IL-1 inhibitors. Not all heterozygous patients had a mild disease course. Sex, age at onset, genotype, attack frequency and inflammatory markers contributed to cluster differentiation. Severe phenotypes were enriched in female patients with early-onset M694V homozygosity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Cluster analysis identified heterogeneous patterns of disease expression, suggesting that the genotype alone does not fully explain clinical variability in FMF. These findings highlight the value of multidimensional approaches to better characterise disease heterogeneity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/rmdopen-2026-006764","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T13:12:37Z","timestamp":1783084357000},"page":"e006764","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond genotype: clustering analysis highlights clinical heterogeneity in paediatric familial Mediterranean fever"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6646-2216","authenticated-orcid":false,"given":"Isild","family":"Mah\u00e9","sequence":"first","affiliation":[{"name":"Paediatric Rheumatology Department, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), H\u00f4pitaux universitaires Paris-Sud - H\u00f4pital Bic\u00eatre, Paris, France"},{"name":"CEREMAIA, Centre de R\u00e9f\u00e9rence des maladies auto-inflammatoires et de l\u2019amylose, Paris, France"},{"name":"Inserm CESP U1018, Universit\u00e9 Paris-Saclay, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Billard","sequence":"additional","affiliation":[{"name":"Inferential Premium Biometry, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6796-6385","authenticated-orcid":false,"given":"Federica","family":"Anselmi","sequence":"additional","affiliation":[{"name":"Paediatric Rheumatology Department, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), H\u00f4pitaux universitaires Paris-Sud - H\u00f4pital Bic\u00eatre, Paris, France"},{"name":"CEREMAIA, Centre de R\u00e9f\u00e9rence des maladies auto-inflammatoires et de l\u2019amylose, Paris, France"},{"name":"Inserm CESP U1018, Universit\u00e9 Paris-Saclay, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Rossi-Semerano","sequence":"additional","affiliation":[{"name":"Paediatric Rheumatology Department, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), H\u00f4pitaux universitaires Paris-Sud - H\u00f4pital Bic\u00eatre, Paris, France"},{"name":"CEREMAIA, Centre de R\u00e9f\u00e9rence des maladies auto-inflammatoires et de l\u2019amylose, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Galeotti","sequence":"additional","affiliation":[{"name":"Paediatric Rheumatology Department, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), H\u00f4pitaux universitaires Paris-Sud - H\u00f4pital Bic\u00eatre, Paris, France"},{"name":"CEREMAIA, Centre de R\u00e9f\u00e9rence des maladies auto-inflammatoires et de l\u2019amylose, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8939-5763","authenticated-orcid":false,"given":"Isabelle","family":"Kone-Paut","sequence":"additional","affiliation":[{"name":"Paediatric Rheumatology Department, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), H\u00f4pitaux universitaires Paris-Sud - H\u00f4pital Bic\u00eatre, Paris, France"},{"name":"CEREMAIA, Centre de R\u00e9f\u00e9rence des maladies auto-inflammatoires et de l\u2019amylose, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8118-0848","authenticated-orcid":false,"given":"Perrine","family":"Dusser","sequence":"additional","affiliation":[{"name":"Paediatric Rheumatology Department, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), H\u00f4pitaux universitaires Paris-Sud - H\u00f4pital Bic\u00eatre, Paris, France"},{"name":"CEREMAIA, Centre de R\u00e9f\u00e9rence des maladies auto-inflammatoires et de l\u2019amylose, Paris, France"},{"name":"Inserm CESP U1018, Universit\u00e9 Paris-Saclay, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"2026070306101422000_12.3.e006764.1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5200776"},{"key":"2026070306101422000_12.3.e006764.2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/7.8.1317"},{"key":"2026070306101422000_12.3.e006764.3","doi-asserted-by":"publisher","DOI":"10.1038\/ng0997-25"},{"key":"2026070306101422000_12.3.e006764.4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.46497\/ArchRheumatol.2020.7769","article-title":"The prevalence of familial Mediterranean fever and Beh\u00e7et\u2019s disease: a cross-sectional study","volume":"35","author":"Alparslan","year":"2020","journal-title":"Arch Rheumatol"},{"key":"2026070306101422000_12.3.e006764.5","doi-asserted-by":"crossref","DOI":"10.1007\/s10238-025-01634-x","article-title":"Unexpectedly high prevalence of familial Mediterranean fever in Slovakia","volume":"25","author":"Jesenak","year":"2025","journal-title":"Clin Exp Med"},{"key":"2026070306101422000_12.3.e006764.6","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206580"},{"key":"2026070306101422000_12.3.e006764.7","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.ard.2025.01.028","article-title":"EULAR\/PReS endorsed recommendations for the management of familial Mediterranean fever (FMF): 2024 update","volume":"84","author":"Ozen","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"2026070306101422000_12.3.e006764.8","first-page":"1","article-title":"Reported triggers and self-reported management strategies in children with familial Mediterranean fever","volume":"32","author":"Kucuk","year":"2026","journal-title":"JCR"},{"key":"2026070306101422000_12.3.e006764.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2009.12.010"},{"key":"2026070306101422000_12.3.e006764.10","first-page":"1061","article-title":"Secondary amyloidosis due to FMF","volume":"54","author":"Yonem","year":"2007","journal-title":"Hepatogastroenterology"},{"key":"2026070306101422000_12.3.e006764.11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00296-017-3796-0","article-title":"Familial Mediterranean fever in childhood: a single-center experience","volume":"38","author":"Barut","year":"2018","journal-title":"Rheumatol Int"},{"key":"2026070306101422000_12.3.e006764.12","first-page":"318","article-title":"Familial Mediterranean fever: clinical, molecular and management advancements","volume":"65","author":"Lidar","year":"2007","journal-title":"Neth J Med"},{"key":"2026070306101422000_12.3.e006764.13","first-page":"709","article-title":"The prevention of amyloidosis in familial Mediterranean fever with colchicine","volume":"21","author":"Cabili","year":"1985","journal-title":"Proc Eur Dial Transpl Assoc Eur Ren Assoc Congr"},{"key":"2026070306101422000_12.3.e006764.14","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780371215"},{"key":"2026070306101422000_12.3.e006764.15","doi-asserted-by":"publisher","DOI":"10.1159\/000186801"},{"key":"2026070306101422000_12.3.e006764.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197410312911804"},{"key":"2026070306101422000_12.3.e006764.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706314"},{"key":"2026070306101422000_12.3.e006764.18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.semarthrit.2017.03.006","article-title":"Colchicine resistance and intolerance in familial Mediterranean fever: definition, causes, and alternative treatments","volume":"47","author":"Ozen","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"2026070306101422000_12.3.e006764.19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.24953\/turkjped.2020.02.001","article-title":"Canakinumab in colchicine resistant familial Mediterranean fever and other pediatric rheumatic diseases","volume":"62","author":"\u00c7akan","year":"2020","journal-title":"Turk J Pediatr"},{"key":"2026070306101422000_12.3.e006764.20","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5200170"},{"key":"2026070306101422000_12.3.e006764.21","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5200303"},{"key":"2026070306101422000_12.3.e006764.22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-200X.2008.02554.x"},{"key":"2026070306101422000_12.3.e006764.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2011.10.012"},{"key":"2026070306101422000_12.3.e006764.24","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.11.1275"},{"key":"2026070306101422000_12.3.e006764.25","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-017-0609-1","article-title":"A survey of resistance to colchicine treatment for French patients with familial Mediterranean fever","volume":"12","author":"Corsia","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"2026070306101422000_12.3.e006764.26","doi-asserted-by":"crossref","DOI":"10.3390\/genes14081562","article-title":"The spectrum of the heterozygous effect in biallelic Mendelian diseases: the symptomatic heterozygote issue","volume":"14","author":"Kalyta","year":"2023","journal-title":"Genes (Basel)"},{"key":"2026070306101422000_12.3.e006764.27","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei279"},{"key":"2026070306101422000_12.3.e006764.28","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep121"},{"key":"2026070306101422000_12.3.e006764.29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00296-019-04391-9","article-title":"Evaluation of co-existing diseases in children with familial Mediterranean fever","volume":"40","author":"Yildiz","year":"2020","journal-title":"Rheumatol Int"},{"key":"2026070306101422000_12.3.e006764.30","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jbspin.2018.01.010","article-title":"Boundaries between familial Mediterranean fever and juvenile spondyloarthritis: analysis of three French retrospective cohorts","volume":"85","author":"Cherqaoui","year":"2018","journal-title":"Joint Bone Spine"},{"key":"2026070306101422000_12.3.e006764.31","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0140-6736(99)02134-0","article-title":"Inflammatory bowel disease in non-Ashkenazi Jews with familial Mediterranean fever","volume":"355","author":"Cattan","year":"2000","journal-title":"The Lancet"},{"key":"2026070306101422000_12.3.e006764.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-0172(97)80007-8"},{"key":"2026070306101422000_12.3.e006764.33","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10067-016-3421-8","article-title":"Discontinuing colchicine in symptomatic carriers for MEFV (Mediterranean FeVer) variants","volume":"36","author":"S\u00f6nmez","year":"2017","journal-title":"Clin Rheumatol"},{"key":"2026070306101422000_12.3.e006764.34","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp632"},{"key":"2026070306101422000_12.3.e006764.35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5152\/TurkArchPediatr.2025.24210","article-title":"Characteristics of siblings with familial Mediterranean fever: a single-center experience","volume":"60","author":"Arslanoglu Aydin","year":"2025","journal-title":"Turk Arch Pediatr"},{"key":"2026070306101422000_12.3.e006764.36","doi-asserted-by":"crossref","first-page":"527","DOI":"10.5152\/TurkArchPediatr.2024.24188","article-title":"Familial Mediterranean fever in childhood","volume":"59","author":"Kisla Ekinci","year":"2024","journal-title":"Turk Arch Pediatr"},{"key":"2026070306101422000_12.3.e006764.37","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1007\/s00431-024-05716-y","article-title":"The impact of different MEFV genotypes on clinical phenotype of patients with familial Mediterranean fever: special emphasis on joint involvement","volume":"183","author":"Aslan","year":"2024","journal-title":"Eur J Pediatr"},{"key":"2026070306101422000_12.3.e006764.38","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215048"},{"key":"2026070306101422000_12.3.e006764.39","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/jamia\/ocab237","article-title":"The ongoing French BaMaRa-BNDMR cohort: implementation and deployment of a nationwide information system on rare disease","volume":"29","author":"Jannot","year":"2022","journal-title":"Journal of the American Medical Informatics Association"},{"key":"2026070306101422000_12.3.e006764.40","doi-asserted-by":"crossref","DOI":"10.1186\/s12969-023-00875-y","article-title":"Treat-to-target strategies for the management of familial Mediterranean Fever in children","volume":"21","author":"Ehlers","year":"2023","journal-title":"Pediatr Rheumatol Online J"},{"key":"2026070306101422000_12.3.e006764.41","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-1434"},{"key":"2026070306101422000_12.3.e006764.42","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.132613"},{"key":"2026070306101422000_12.3.e006764.43","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3906\/sag-2008-11","article-title":"Familial Mediterranean fever, from pathogenesis to treatment: a contemporary review","volume":"50","author":"Tufan","year":"2020","journal-title":"Turk J Med Sci"},{"key":"2026070306101422000_12.3.e006764.44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068431","article-title":"The risk of familial Mediterranean fever in MEFV heterozygotes: a statistical approach","volume":"8","author":"J\u00e9ru","year":"2013","journal-title":"PLoS ONE"},{"key":"2026070306101422000_12.3.e006764.45","doi-asserted-by":"publisher","DOI":"10.1038\/jhg.2010.52"},{"key":"2026070306101422000_12.3.e006764.46","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jbspin.2020.01.005","article-title":"Typical familial Mediterranean fever associated with the heterozygous missense sequence p.T577N variant of the MEFV gene: report on two Northern European Caucasian relatives in France","volume":"87","author":"Elhani","year":"2020","journal-title":"Joint Bone Spine"},{"key":"2026070306101422000_12.3.e006764.47","doi-asserted-by":"crossref","DOI":"10.1177\/2333794X241274752","article-title":"Heterozygous MEFV mutation leading to renal failure: a case study","volume":"11","author":"El Gazzane","year":"2024","journal-title":"Glob Pediatr Health"},{"key":"2026070306101422000_12.3.e006764.48","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-024-03440-4","article-title":"The needed daily dose of colchicine in patients with familial Mediterranean fever may be higher in women: a study on behalf of the JIR cohort","volume":"27","author":"Di Cola","year":"2025","journal-title":"Arthritis Res Ther"},{"key":"2026070306101422000_12.3.e006764.49","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012305","article-title":"Subclinical inflammation in a case of menstruation-induced familial Mediterranean fever: a case report","volume":"97","author":"Hara","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"2026070306101422000_12.3.e006764.50","first-page":"261","article-title":"Serum 17-OH progesterone and free testosterone levels in women patients with familial Mediterranean fever: a pivotal study","volume":"17","author":"Deveci","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2026-006764","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T13:12:42Z","timestamp":1783084362000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2026-006764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":50,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,7,3]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/rmdopen-2026-006764"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2026-006764","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}